D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
MetLife
MET
$62.4B
| $4.18M | ﹤0.01% |
59,541
-390,551
| -87% | -$26.4M |
|
2377
CALL
Take-Two Interactive
TTWO
$46.1B
| $4.18M | ﹤0.01% |
27,200
-52,300
| -66% | -$8.37M |
|
|
ACII
2378
DELISTED
Atlas Crest Investment Corp. II
ACII
| $4.17M | ﹤0.01% |
424,132
+118,488
| +39% | +$1.15M |
|
2379
Hope Bancorp
HOPE
$1.8B
| $4.16M | ﹤0.01% |
258,965
-36,922
| -12% | -$609K |
|
2380
Celldex Therapeutics
CLDX
$2.95B
| $4.16M | ﹤0.01% |
122,172
-52,613
| -30% | -$1.68M |
|
|
TWLV
2381
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
| $4.16M | ﹤0.01% |
425,581
-548,549
| -56% | -$5.33M |
|
|
RNER
2382
DELISTED
Mount Rainier Acquisition Corp. Common Stock
RNER
| $4.16M | ﹤0.01% |
+416,578
| New | +$4.14M |
|
2383
Flowserve
FLS
$8.94B
| $4.15M | ﹤0.01% |
115,736
-686,530
| -86% | -$22.4M |
|
2384
Brinker International
EAT
$8.83B
| $4.15M | ﹤0.01% |
108,844
-123,509
| -53% | -$4.62M |
|
|
PRPC
2385
DELISTED
CC Neuberger Principal Holdings III
PRPC
| $4.15M | ﹤0.01% |
420,718
-90,304
| -18% | -$884K |
|
2386
Delek US
DK
$3.98B
| $4.14M | ﹤0.01% |
195,231
+91,440
| +88% | +$1.66M |
|
2387
PUT
Western Alliance Bancorporation
WAL
$8.81B
| $4.14M | ﹤0.01% |
50,000
+16,300
| +48% | +$1.6M |
|
|
SSAA
2388
DELISTED
Science Strategic Acquisition Corp. Alpha Class A Common Stock
SSAA
| $4.14M | ﹤0.01% |
422,073
-737,399
| -64% | -$7.19M |
|
|
VRAY
2389
DELISTED
ViewRay, Inc.
VRAY
| $4.13M | ﹤0.01% |
1,054,061
+552,296
| +110% | +$2.35M |
|
2390
Hanmi Financial
HAFC
$936M
| $4.13M | ﹤0.01% |
167,709
-48,877
| -23% | -$1.26M |
|
2391
SHF Holdings
SHFS
$1.12M
| $4.13M | ﹤0.01% |
20,390
| – | – |
|
|
BFAC
2392
DELISTED
Battery Future Acquisition Corp.
BFAC
| $4.13M | ﹤0.01% |
+416,666
| New | +$4.11M |
|
|
INFN
2393
DELISTED
Infinera Corporation Common Stock
INFN
| $4.13M | ﹤0.01% |
475,847
+259,921
| +120% | +$2.23M |
|
2394
Linde
LIN
$236B
| $4.11M | ﹤0.01% |
12,879
+9,321
| +262% | +$2.88M |
|
2395
PUT
West Pharmaceutical
WST
$23.7B
| $4.11M | ﹤0.01% |
10,000
-15,400
| -61% | -$6.03M |
|
|
AHRNU
2396
DELISTED
Ahren Acquisition Corp Unit
AHRNU
| $4.1M | ﹤0.01% |
407,502
-200,000
| -33% | -$2M |
|
2397
Williams Companies
WMB
$85.8B
| $4.1M | ﹤0.01% |
122,586
-1,590,305
| -93% | -$48.6M |
|
|
GDNR
2398
DELISTED
Gardiner Healthcare Acquisitions Corp. Common Stock
GDNR
| $4.09M | ﹤0.01% |
+413,469
| New | +$4.07M |
|
2399
Federal Realty Investment Trust
FRT
$10.9B
| $4.09M | ﹤0.01% |
33,483
+9,146
| +38% | +$1.13M |
|
2400
PUT
Parker-Hannifin
PH
$120B
| $4.09M | ﹤0.01% |
+14,400
| New | +$4.34M |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.